DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Byong-Seok | ko |
dc.contributor.author | Lee, Janghyun | ko |
dc.date.accessioned | 2019-09-19T02:20:33Z | - |
dc.date.available | 2019-09-19T02:20:33Z | - |
dc.date.issued | 2019-07-03 | - |
dc.identifier.uri | http://hdl.handle.net/10203/267589 | - |
dc.description.abstract | The present invention provides an antiviral agent comprising an RNA oligonucleotide having a particular sequence and structure. Specifically, when a cell line is treated with an RNA oligonucleotide having specific sequence and helical bend structure according to the present invention, the expression of interferon-β or ISG56 is increased and anti-viral activating is exhibited. Thus, a composition comprising the RNA oligonucleotide can be used as an antiviral agent. | - |
dc.title | ANTIVIRAL AGENT COMPRISING RNA OLIGONUCLEOTIDE | - |
dc.title.alternative | RNA 올리고뉴클레오티드를 포함하는 항바이러스제 | - |
dc.type | Patent | - |
dc.type.rims | PAT | - |
dc.contributor.localauthor | Choi, Byong-Seok | - |
dc.contributor.assignee | KAIST | - |
dc.identifier.iprsType | 특허 | - |
dc.identifier.patentApplicationNumber | 16798376.6 | - |
dc.identifier.patentRegistrationNumber | 3195882 | - |
dc.date.application | 2016-11-30 | - |
dc.date.registration | 2019-07-03 | - |
dc.publisher.country | EI | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.